Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1986
Report date:
1986

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
no
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
Available existing study.

Test material

Constituent 1
Reference substance name:
Tyzor IAM
IUPAC Name:
Tyzor IAM
Constituent 2
Chemical structure
Reference substance name:
Butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium(trialkyloxy)titanium phosphate
EC Number:
401-100-0
EC Name:
Butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium(trialkyloxy)titanium phosphate
Cas Number:
109037-78-7
Molecular formula:
C12 H27 O13 P2 Ti2 R5 Where R = (C2H5)x or (iC3H7)y where x = 0 to 5 and y = 0 to 5 and x+y = 5
IUPAC Name:
Butyl [dialkoxy(dibutyl-phosphato)titanium] (trialkoxytitanium)phosphate
Details on test material:
Manufacturer: DuPont. Source: commercial production. Intended use: adhesion promoter. Appearance: clear, colourless liquid. Storage: under nitrogen at 20-25°C. Batch: Lot 106. Manufacture: 2003-02-10. Immediate cloudiness and precipitation of solids are known to result from the Tyzor IAM coming into contact with aqueous solutions.

In vivo test system

Test animals

Species:
guinea pig
Strain:
Dunkin-Hartley
Sex:
female

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
other: intradermal injections and topical applications
Vehicle:
other: 5% v/v Acetone in Alembicol D for intradermal injection and as supplied for topical application.
Concentration / amount:
Concentration of test material and vehicle used at induction:
a) 0.5% v/v in acetone containing 5% w/v alembicol D
b) Undiluted

Concentration of test material and vehicle used for each challenge:
20% and 50% v/v in acetone
Challengeopen allclose all
Route:
other: topical applications
Vehicle:
other: 5% v/v Acetone in Alembicol D for intradermal injection and as supplied for topical application.
Concentration / amount:
Concentration of test material and vehicle used at induction:
a) 0.5% v/v in acetone containing 5% w/v alembicol D
b) Undiluted

Concentration of test material and vehicle used for each challenge:
20% and 50% v/v in acetone
No. of animals per dose:
Number of animals in test group: 20
Number of animals in negative control group: 20
Challenge controls:
Two weeks after induction, test and control animals were challenged topically with test substance at 50% and 20% v/v in acetone. Patches were applied for 24 hours and sites were evaluated 24, 48 and 72 hours after removal.
Positive control substance(s):
no

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
72
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
3
Total no. in group:
20
Clinical observations:
Positive evidence of delayed contact hypersensitivity
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 72.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: Positive evidence of delayed contact hypersensitivity.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
8
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 8.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible).
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
3
Total no. in group:
20
Clinical observations:
Oedema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: Oedema (barely perceptible).
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
20% v/v in acetone
No. with + reactions:
3
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 20% v/v in acetone. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
20% v/v acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 20% v/v acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible).
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
20% v/v acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Oedema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 20% v/v acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Oedema (barely perceptible).
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
3
Total no. in group:
20
Clinical observations:
Erythema (well defined) - dryness and sloughing of the epidermis observed
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: Erythema (well defined) - dryness and sloughing of the epidermis observed.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
4
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 4.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible).
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
3
Total no. in group:
20
Clinical observations:
Oedema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: Oedema (barely perceptible).
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
20% v/v in acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 20% v/v in acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
20% v/v in acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Erythema (well defined) - dryness and sloughing of the epidermis observed
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 20% v/v in acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Erythema (well defined) - dryness and sloughing of the epidermis observed.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
20% v/v in acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - dryness and sloughing of the epidermis observed
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 20% v/v in acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - dryness and sloughing of the epidermis observed.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
20% v/v in acetone
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
Oedema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 20% v/v in acetone. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: Oedema (barely perceptible).
Reading:
1st reading
Hours after challenge:
72
Group:
test chemical
Dose level:
50% v/v in acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - dryness and sloughing of the epidermis observed
Remarks on result:
other: see Remark
Remarks:
Reading: 1st reading. . Hours after challenge: 72.0. Group: test group. Dose level: 50% v/v in acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - dryness and sloughing of the epidermis observed.
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
50% v/v in acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 50% v/v in acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible).
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
50% v/v in acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 50% v/v in acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
20% v/v in acetone
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Erythema (barely perceptible) - localised dermal reaction
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 20% v/v in acetone. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Erythema (barely perceptible) - localised dermal reaction.

Any other information on results incl. tables

Evidence of sensitisation of each challenge concentration:
Evidence of sensitisation was observed in 3 animals.

Applicant's summary and conclusion

Interpretation of results:
other: not classified
Conclusions:
The test substance is not classified as a skin sensitiser. The study indicated that positive evidence of skin sensitisation was observed in 3 animals.
Executive summary:

Seaber (1986) is a skin sensitisation study following OECD guideline 406. The study is considered reliable without restriction and suitable for use for this endpoint.